|1||Active, not recruiting||
CRLX101 Plus Bevacizumab in Advanced RCC
A Phase 2 Study of CRLX101 in Patients With Advanced Non-Small Cell Lung Cancer
|3||Active, not recruiting||
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
† Study has passed its completion date and status has not been verified in more than two years.